Amidst a ton of excited posts and fda discussion, unless I've not read back far enough has someone hear dived into addressable market size which would give a clearer view for future valuation?
Ann: Positive IHL-675A in vivo results and FDA Pathway, page-65
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)